In April, Dr. Andrew Tie presented the following poster at the 2025 Congress of the European Society of Clinical Microbiology and Infectious Diseases. This work, originated by John Aitken’s team at Otakaro Pathways, shows mycobacteria in the ileal tissue of all tested Crohn’s disease subjects (18/18) and none in healthy controls (0/15).
Please enjoy the latest MAP research update by John Aitken of Otakaro Pathways.
Thanks to the commitment of MAP researchers around the world and the generosity of the Human Para community to sponsor MAP research, there are three recent publications of interest.
Dr. Click passed away on December 7, 2023. While we mourn his loss, we also celebrate the monumental contribution he made to advancing MAP science and hope that his tireless work with Dietzia may soon be celebrated by those afflicted by MAP-associated human disease.
HPF is proud to share the latest MAP research showcased by Dr. William Chamberlin at the 2023 UEG conference.
Human Paratuberculosis Foundation is dedicated to providing the latest research and information about the role of Mycobacterium avium subsp. paratuberculosis (MAP) in chronic immune conditions such as Crohn’s disease, multiple sclerosis, Type 1 diabetes, ulcerative colitis, sarcoidosis, Parkinson’s disease, rheumatoid arthritis, lupus and more. Our goal is to assist researchers, health care professionals and patients around the world. We are grateful for the support of our community and look forward to taking this journey together. Enjoy the latest edition of our quarterly newsletter!
In Maori the saying ‘Kua hinga te tōtara o Te Waonui a Tāne” roughly translates to “In the forest of Tāne a great Totara has fallen.” A Totara is a tree which was of great value. The proverb is used when a person of influence and mana passes on. It most certainly applies to Prof. John Hermon-Taylor.
A recent article published in Pathology showed that 18/18 intestinal resection samples from Crohn’s disease patients contained mycobacteria. In contrast, none of the 15 samples from control subjects were positive.
Human Paratuberculosis Foundation is dedicated to providing the latest research and information about the role of Mycobacterium avium subsp. paratuberculosis (MAP) in chronic immune conditions such as Crohn’s disease, multiple sclerosis, Type 1 diabetes, ulcerative colitis, sarcoidosis, Parkinson’s disease, rheumatoid arthritis, lupus and more. Our goal is to assist researchers, health care professionals and patients around the world. We are grateful for the support of our community and look forward to taking this journey together. Enjoy the latest edition of our quarterly newsletter!
This week the world lost a friend, colleague and advocate for IBD patients. For decades, Patrick McLean dedicated his talents to advancing research into anti-mycobacterial treatment solutions for chronic immune diseases such as Crohn’s and multiple sclerosis. He had great compassion for patients, and exemplified the best of humanity. Our community was blessed to have known him, and he leaves a legacy that will ripple throughout time.
